Impact of angiotensin-converting enzyme inhibitors (ACEi) on pathologic complete response with neoadjuvant chemotherapy (NAC) for muscle-invasive bladder cancer (MIBC).

Authors

null

Jonathan Thomas

Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA

Jonathan Thomas , William Paul Skelton IV, Parvaneh Fallah , Rohit K. Jain , Praful Ravi , Charlene Mantia , Bradley Alexander McGregor , Pier Vitale Nuzzo , Elio Adib , Talal El Zarif , Catherine Curran , Mark A. Preston , Timothy Nguyen Clinton , Roger Li , Graeme S. Steele , Wassim Kassouf , Dory Freeman , Gregory Russell Pond , Rakesh K. Jain , Guru P. Sonpavde

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Urothelial Carcinoma

Track

Urothelial Carcinoma

Sub Track

Therapeutics

Citation

J Clin Oncol 40, 2022 (suppl 6; abstr 485)

DOI

10.1200/JCO.2022.40.6_suppl.485

Abstract #

485

Poster Bd #

E6

Abstract Disclosures